SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-017299
Filing Date
2016-05-02
Accepted
2016-05-02 16:11:22
Documents
61
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adro-10q_20160331.htm 10-Q 1868828
2 EX-10.1 adro-ex101_537.htm EX-10.1 243085
3 EX-31.1 adro-ex311_204.htm EX-31.1 13059
4 EX-31.2 adro-ex312_203.htm EX-31.2 13170
5 EX-32.1 adro-ex321_202.htm EX-32.1 13285
  Complete submission text file 0001564590-16-017299.txt   6971959

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adro-20160331.xml EX-101.INS 1544674
7 XBRL TAXONOMY EXTENSION SCHEMA adro-20160331.xsd EX-101.SCH 44873
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adro-20160331_cal.xml EX-101.CAL 48308
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adro-20160331_def.xml EX-101.DEF 135536
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adro-20160331_lab.xml EX-101.LAB 367807
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adro-20160331_pre.xml EX-101.PRE 272248
Mailing Address 626 BANCROFT WAY SUITE 3-C BERKELEY CA 94710
Business Address 626 BANCROFT WAY SUITE 3-C BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 161611764
SIC: 2834 Pharmaceutical Preparations